Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression

Stem Cells and Development

Volumn 23, Issue 23, 2014, Pages 2851-2861

  Lee, Hae Kyung ^a   Finniss, Susan ^a   Cazacu, Simona ^a   Xiang, Cunli ^a   Brodie, Chaya ^a,b  

^a Hermelin Brain Tumor Center   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE TRANSPORTER; MICRORNA 124; MICRORNA 145; TRANSCRIPTION FACTOR SOX9; 3' UNTRANSLATED REGION; EXCITATORY AMINO ACID TRANSPORTER 1; MICRORNA; MIRN124 MICRORNA, HUMAN; MIRN145 MICRORNA, HUMAN; SLC1A2 PROTEIN, HUMAN; SLC1A3 PROTEIN, HUMAN; SOX9 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; ASTROCYTE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CONTACT; CONTROLLED STUDY; EXOSOME; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGENERATIVE MEDICINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM;

3' UNTRANSLATED REGIONS; CELL DIFFERENTIATION; EXCITATORY AMINO ACID TRANSPORTER 1; GENE EXPRESSION REGULATION; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; NEURAL STEM CELLS; SOX9 TRANSCRIPTION FACTOR;

EID: 84911422987     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0146     Document Type: Article

References (59)

1. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
2. Schickel R, B Boyerinas, SM Park and ME Peter. (2008). MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27:5959-5974.
3. Madathil SK, PT Nelson, KE Saatman and BR Wilfred. (2011). MicroRNAs in CNS injury: potential roles and therapeutic implications. Bioessays 33:21-26.
4. De Smaele E, E Ferretti and A Gulino. (2010). MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res 1338:100-111.
5. Maciotta S, M Maregalli and Y Torrente. (2013). The invovlement of microRNAs in neurodegenerative diseases. Front Cell Neurosci 7:265-282.
6. Bhalala OG, M Srikanth and JA Kessler. (2013). Nat Rev Neurol 9:328-339.
7. Tan JR, YX Koo, P Kaur, F Liu, A Armugam, PT Wong and K Jeyaseelan. (2011). microRNAs in stroke pathogenesis. Curr Mol Med 11:76-92.
8. Vemuganti R. (2010). The MicroRNAs and stroke: no need to be coded to be counted. Transl Stroke Res 1:158-160.
9. Saugstad JA. (2010). MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J Cereb Blood Flow Metab 30: 1564-1576.
10. Redell JB, Y Liu and PK Dash. (2009). Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res 87:1435-1448.
11. Mouradian MM. (2012). MicroRNAs in Parkinson's disease. Neurobiol Dis 46:279-284.
12. Arias-Carrion O and M Salama. (2011). Reprogramming neurons by microRNAs into iPSCs to treat Parkinson's disease. Med Hypotheses 77:312-313.
13. Harraz MM, TM Dawson and VL Dawson. (2011). MicroRNAs in Parkinson's disease. J Chem Neuroanat 42:127-130.
14. Delay C, W Mandemakers and SS Hebert. (2012). Micro-RNAs in Alzheimer's disease. Neurobiol Dis 46:285-290.
15. Junn E and MM Mouradian. (2012). MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133:142-150.
16. Ahmed AU, NG Alexiades and MS Lesniak. (2010). The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. Curr Opin Mol Ther 12:546-552.
17. Choi SA, JY Lee, KC Wang, JH Phi, SH Song, J Song and SK Kim. (2012). Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur J Cancer 48:129-137.
18. Amano S, S Li, C Gu, Y Gao, S Koizumi, S Yamamoto, S Terakawa and H Namba. (2009). Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. Int J Oncol 35:1265-1270.
19. Spaeth E, A Klopp, J Dembinski, M Andreeff and F Marini. (2008). The inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 15:730-738.
20. Olson SD, K Pollock, A Kambal, W Cary, GM Mitchell, J Tempkin, H Stewart, J McGee, G Bauer, et al. (2012). Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol 45:87-98.
21. Joyce N, G Annett, L Wirthlin, S Olson, G Bauer and JA Nolta. (2010). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5:933-946.
22. Zhang J and M Chopp. (2013). Cell-based therapy for ischemic stroke. Expert Opin Biol Ther 13:1229-1240.
23. Meyerrose T, S Olson, S Pontow, S Kalomoiris, Y Jung, G Annett, G Bauer and JA Nolta. (2010). Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 62:1167-1174.
24. Karussis D, I Kassis, BG Kurkalli and S Slavin. (2008). Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 265:131-135.
25. Sonabend AM, IV Ulasov, MA Tyler, AA Rivera, JM Mathis and MS Lesniak. (2008). Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 26:831-841.
26. Lee HK, S Finniss, S Cazacu, E Bucris, A Ziv-Av, C Xiang, K Bobbitt, SA Rempel, L Hasselbach, et al. (2013). Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget 4:346-361.
27. Lee HK, A Bier, S Cazacu, S Finniss, C Xiang, H Twito, LM Poisson, T Mikkelsen, S Slavin, et al. (2013). Micro-RNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One 8:e54652.
28. Bier A, N Giladi, N Kronfeld, HK Lee, S Cazacu, S Finniss, C Xiang, L Poisson, AC de Carvalho, et al. (2013). MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 4:665-676.
29. Kan I, Y Barhum, E Melamed and D Offen. (2011). Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev 7: 404-412.
30. Park HJ, JY Shin, BR Lee, HO Kim and PH Lee. (2012). Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model. Cell Transplant 21:1629-1640.
31. Morel L, M Regan, H Higashimori, SK Ng, C Esau, S Vidensky, J Rothstein and Y Yang. (2013). Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem 288: 7105-7116.
32. Ha TY. (2011). MicroRNAs in human diseases: from autoimmune diseases to skin, psychiatric and neurodegenerative diseases. Immune Netw 11:227-244.
33. Junn E and MM Mouradian. (2010). MicroRNAs in neurodegenerative disorders. Cell Cycle 9:1717-1721.
34. Roshan R, T Ghosh, V Scaria and B Pillai. (2009). MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov Today 14:1123-1129.
35. Krichevsky AM, KC Sonntag, O Isacson and KS Kosik. (2006). Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24:857-864.
36. Danielyan L, R Schafer, A von Ameln-Mayerhofer, F Bernhard, S Verleysdonk, M Buadze, A Lourhmati, T Klopfer, F Schaumann, et al. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 14:3-16.
37. Olson SD, A Kambal, K Pollock, GM Mitchell, H Stewart, S Kalomoiris, W Cary, C Nacey, K Pepper and JA Nolta. (2012). Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Mol Cell Neurosci 49: 271-281.
38. Visvanathan J, S Lee, B Lee, JW Lee and SK Lee. (2007). The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev 21:744-749.
39. Sun Y, H Gui, Q Li, ZM Luo, MJ Zheng, JL Duan and X Liu. (2013). MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke. CNS Neurosci Ther 19: 813-819.
40. Laine SK, JJ Alm, SP Virtanen, HT Aro and TK Laitala-Leinonen. (2012). MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bonemarrow-derived mesenchymal stem cells. J Cell Biochem 113:2687-2695.
41. Liu XS, M Chopp, RL Zhang, T Tao, XL Wang, H Kassis, A Hozeska-Solgot, L Zhang, C Chen and ZG Zhang. (2011). MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS One 6: e23461.
42. Makeyev EV, J Zhang, MA Carrasco and T Maniatis. (2007). The microRNA miR-124 promotes neuronal differentiation by triggering brain-sepcific alternative pre-RNA splicing. Mol Cell 27:435-448.
43. Scott CE, SL Wynn, A Sesay, C Cruz, M Cheung, MV Gomez Gaviro, S Booth, B Gao, KS Cheah, R Lovell-Badge and J Briscoe. (2010). SOX9 induces and maintains neural stem cells. Nat Neurosci 13:1181-1189.
44. Kim K, SG Lee, TP Kegelman, ZZ Su, SK Das, R Dash, S Dasgupta, PM Barral, M Hedvat, et al. (2011). Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226:2484-2493.
45. Gilley JA and SG Kernie. (2011). Excitatory amino acid transporter 2 and excitatory amino acid transporter 1 negatively regulate calcium-dependent proliferation of hippocampal neural progenitor cells and are persistently upregulated after injury. Eur J Neurosci 34:1712-1723.
46. Maragakis NJ, J Dietrich, V Wong, H Xue, M Mayer-Proschel, MS Rao and JD Rothstein. (2004). Glutamate transporter expression and function in human glial progenitors. Glia 45:133-143.
47. Maragakis NJ, M Dykes-Hoberg and JD Rothstein. (2004). Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol 55:469-477.
48. Duerson K, RL Woltjer, P Mookherjee, JB Leverenz, TJ Montine, TD Bird, DV Pow, T Rauen and DG Cook. (2009). Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients. Brain Pathol 19:267-278.
49. Foran E and D Trotti. (2009). Glutamate transporters and the excitotoxic path tomotor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 11:1587-1602.
50. Okabe Y, T Takahashi, C Mitsumasu, K Kosai, E Tanaka and T Matsuishi. (2012). Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One 7:e35354.
51. Poblete-Naredo I, C Angulo, L Hernandez-Kelly, E Lopez-Bayghen, J Aguilera and A Ortega. (2009). Insulin-dependent regulation of GLAST/EAAT1 in Bergmann glial cells. Neurosci Lett 451:134-138.
52. Aguirre G, S Rosas, E Lopez-Bayghen and A Ortega. (2008). Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1. Neurochem Int 52:1322-1331.
53. Karki P, A Webb, K Smith, K Lee, DS Son, M Aschner and E Lee. (2013). cAMP response element-binding protein (CREB) and nuclear factor kappaB mediate the tamoxifeninduced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytes. J Biol Chem 288:28975-28986.
54. Ponomarev ED, T Veremeyko, N Barteneva, AM Krichevsky and HL Weiner. (2011). MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med 17:64-70.
55. Kosaka N, H Iguchi, Y Yoshioka, F Takeshita, Y Matsuki and T Ochiya. (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442-17452.
56. Lau CS and DT Wong. (2012). Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 7:e33037.
57. Palazzolo G, NN Albanese, G DIC, D Gygax, ML Vittorelli and I Pucci-Minafra. (2012). Proteomic analysis of exosome-like vesicles derived from breast cancer cells. Anticancer Res 32:847-860.
58. Katakowski M, B Buller, X Zheng, Y Lu, T Rogers, O Osobamiro, W Shu, F Jiang and M Chopp. (2013). Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335:201-204.
59. Munoz JL, SA Bliss, SJ Greco, SH Ramkissoon, KL Ligon and P Rameshwar. (2013). Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids 2:e126.